GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson ...
The companies have identified an initial set of genetic biomarkers to predict drug response and will validate the findings in ...
AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...
Twenty percent of potentially eligible youth are prescribed GLP-1 RAs, with the odds of prescription higher with increasing ...
Stimulant medications can make some people have a smaller appetite. If you take both a GLP-1 and a stimulant, you might not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results